Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol Sedation and Neuromediator Concentrations
NCT04695509Completed
- Sponsor
- Sechenov First Moscow State Medical University
- Start
- Oct 2020
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of propofol, sponsored by Sechenov First Moscow State Medical University. Primary endpoints: Dopamine concentration and Serotonin concentration. Started Oct 2020; status: completed.
02
Drugs
propofol
Beyond the preview
Go deeper on NCT04695509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04695509.